Comparison of the effect of intravitreal injection of bevacizumab with posterior subtenon injection of triamcinolone in diffuse diabetic macular oedema

Background: Diffuse diabetic macular oedema (DDME) is the leading cause of visual impairment in patients of long-standing diabetes mellitus. The time-tested intervention for the treatment of macular oedema and the prevention of its progression is intravitreal or posterior subtenon steroid injection,...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rohini Grover, Amit Khosla, H K Tewari, S N Jha, Neeraj Manchanda, Tinku Bali, Nidhi Panwar, Anita Singh
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer Medknow Publications 2011-01-01
coleção:	Current Medicine Research and Practice
Assuntos:	ddme bevacizumab central macular thickness bcva oct
Acesso em linha:	http://www.cmrpjournal.org/article.asp?issn=2352-0817;year=2011;volume=1;issue=6;spage=306;epage=310;aulast=Grover
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!